-
1دورية أكاديمية
المؤلفون: Heidi Ko, Rebecca A. Previs, Kyle C. Strickland, Jonathan Klein, Brian Caveney, Chiara Chiruzzi, Marcia Eisenberg, Eric A. Severson, Shakti Ramkissoon, Kamal S. Saini
المصدر: Oncology and Therapy, Vol 12, Iss 1, Pp 13-17 (2023)
مصطلحات موضوعية: HER2-low, Metastatic breast cancer, HER2 testing, HER2-directed antibody–drug conjugate, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Pathmanathan Rajadurai, Sarala Ravindran, Bang Rom Lee, Suria Hayati Md Pauzi, Seow Fan Chiew, Kean Hooi Teoh, Navarasi S. Raja Gopal, Mastura Md Yusof, Cheng Har Yip
المصدر: Cancers, Vol 16, Iss 13, p 2325 (2024)
مصطلحات موضوعية: breast cancer, HER2 testing, HER2-low scoring, consensus statement, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Huiping Zhao, Pan Liang, Liuliang Yong, Ming Cheng, Yan Zhang, Minggang Huang, Jianbo Gao
المصدر: Insights into Imaging, Vol 14, Iss 1, Pp 1-13 (2023)
مصطلحات موضوعية: Computed tomography, Radiomics, Nomogram, HER2 testing, Gastric cancer, Medical physics. Medical radiology. Nuclear medicine, R895-920
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1869-4101Test
-
4دورية أكاديمية
المصدر: International Journal of Molecular Sciences; Volume 24; Issue 9; Pages: 8206
مصطلحات موضوعية: HER2 low, HER2 overexpression, HER2 amplification, HER2 testing, antibody drug conjugate, trastuzumab deruxtecan, T-DXd, HER2 heterogeneity, HER2-enriched
جغرافية الموضوع: agris
وصف الملف: application/pdf
العلاقة: Molecular Oncology; https://dx.doi.org/10.3390/ijms24098206Test
-
5دورية أكاديمية
المؤلفون: Kaufman, Peter A, Bloom, Kenneth J, Burris, Howard, Gralow, Julie R, Mayer, Musa, Pegram, Mark, Rugo, Hope S, Swain, Sandra M, Yardley, Denise A, Chau, Miu, Lalla, Deepa, Yoo, Bongin, Brammer, Melissa G, Vogel, Charles L
المصدر: Cancer. 120(17)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Biotechnology, Cancer, Breast Cancer, Detection, screening and diagnosis, 4.2 Evaluation of markers and technologies, Biomarkers, Tumor, Breast Neoplasms, False Negative Reactions, Female, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Middle Aged, Prospective Studies, Receptor, ErbB-2, Sensitivity and Specificity, breast cancer, human epidermal growth factor receptor 2, immunohistochemistry, fluorescence in situ hybridization, local and central HER2 testing, discordance rate, Receptor, erbB-2, Public Health and Health Services, Oncology & Carcinogenesis, Oncology and carcinogenesis, Public health
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/3w92f356Test
-
6دورية أكاديمية
المؤلفون: Sazonov, S. V., Сазонов, С. В.
مصطلحات موضوعية: BREAST CANCER, IMMUNOHISTOCHEMICAL STUDIES, HER2 TESTING, MOLECULAR BIOLOGICAL STUDIES, ISH-METHOD, REFERENCE STUDIES, QUALITY CONTROL DIAGNOSTICS, РАК МОЛОЧНОЙ ЖЕЛЕЗЫ, ИММУНОГИСТОХИМИЧЕСКИЕ ИССЛЕДОВАНИЯ, HER2 ТЕСТИРОВАНИЕ, МОЛЕКУЛЯРНО-БИОЛОГИЧЕСКИЕ ИССЛЕДОВАНИЯ, ISH-МЕТОД, РЕФЕРЕНСНЫЕ ИССЛЕДОВАНИЯ, КОНТРОЛЬ КАЧЕСТВА ДИАГНОСТИКИ
وصف الملف: application/pdf
العلاقة: Уральский медицинский журнал. 2020. № 2(185).; Сазонов, С. В. Обеспечение качества молекулярно-генетической диагностики рака молочной железы / С. В. Сазонов. – Текст: электронный // Уральский медицинский журнал. - 2020. – № 2(185). – С. 62-66.; http://elib.usma.ru/handle/usma/18897Test
-
7دورية أكاديمية
المؤلفون: M B Berdimyradova, S M Khadjiev, D N Khommadova, G O Polatova, A O Kakajanova, Ch B Batyrov, D N Penayev, B G Agayeva, G A Annaberdiyeva
المصدر: Современная онкология, Vol 20, Iss 2, Pp 42-44 (2018)
مصطلحات موضوعية: her2-positive breast cancer, the programme of early diagnosis and treatment of her2-positive breast cancer in turkmenistan, her2 testing results in turkmenistan, neoadjuvant systemic therapy, complete morphological response, 10.26442/1815-1434_2018.2.42-44, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://modernonco.orscience.ru/1815-1434/article/viewFile/29549/pdfTest; https://doaj.org/toc/1815-1434Test; https://doaj.org/toc/1815-1442Test
-
8دورية أكاديمية
المؤلفون: Ivkovic-Kapic Tatjana, Knežević-Ušaj Slavica, Moldvaji Eva, Jovanić Irena, Milovanović Zorka, Milentijević Maja, Tatić Svetislav, Mitrovic Slobodanka, Stojiljković Miodrag, Cvetanović Ana
المصدر: J BUON 24(3) 1045-1053
مصطلحات موضوعية: HER2 testing, breast cancer, inter-laboratory consensus, quality control
العلاقة: https://zenodo.org/communities/iorsTest; https://zenodo.org/record/4486675Test; https://doi.org/10.5281/zenodo.4486675Test; oai:zenodo.org:4486675
الإتاحة: https://doi.org/10.5281/zenodo.4486675Test
https://doi.org/10.5281/zenodo.4486674Test
https://zenodo.org/record/4486675Test -
9دورية أكاديمية
المؤلفون: Halle, Mari Kyllesø, Tangen, Ingvild Løberg, Berg, Hege Fredriksen, Hoivik, Erling A, Mauland, Karen Klepsland, Kusonmano, Kanthida, Berg, Anna, Hurtado, Antoni, Kalland, Karl-Henning, Øyan, Anne Margrete, Stefansson, Ingunn, Vintermyr, Olav Karsten, Werner, Henrica Maria Johanna, Haldorsen, Ingfrid S., Trovik, Jone, Salvesen, Helga Birgitte, Krakstad, Camilla
المصدر: British Journal of Cancer
مصطلحات موضوعية: HER2 testing, HercepTest, endometrial carcinoma, prognostic biomarkers, chromogenic in situ hybridisation, metastatic biopsies, antibody-drugs conjugate, trastuzumab
وصف الملف: application/pdf
العلاقة: Molecular alterations suggesting new treatment strategies in uterine carcinomas; urn:issn:1532-1827; urn:issn:0007-0920; https://hdl.handle.net/1956/16983Test; https://doi.org/10.1038/bjc.2017.422Test
-
10دورية أكاديمية
المؤلفون: H. Chung C., Y-J. Bang, J. Xu M., F. Lordick, A. Sawaki, O. Lipatov, M. Lehle, М. Pickl, J. Ruschoff, E. Cutsem Van, Х. Чанг К., Уай-Джей Бенг, Дж. Ху М., Ф. Лордик, А. Саваки, О. Липатов, М. Леле, М. Пикл, Дж. Рюшофф, Е. Кутцем Ван
المصدر: Creative surgery and oncology; № 4 (2013); 16-22 ; Креативная хирургия и онкология; № 4 (2013); 16-22 ; 2076-3093 ; 2307-0501 ; 10.24060/2076-3093-2013-0-4
مصطلحات موضوعية: gastric cancer, chemotherapy, HER2 testing, trastuzumab, рак желудка, химиотерапия, тест HER2, трастузумаб
وصف الملف: application/pdf
العلاقة: https://www.surgonco.ru/jour/article/view/185/189Test; Barok M., Isola J., Palyi-Krekk Z. et al. Trastuzumab causes antibody-dependent cellular cytotoxicitymediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance // Mol. Cancer Ther. 2007. Vol. 6. P. 2065-2072.; Fujimoto Duchi K. et al. Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models // Cancer Chemother. Pharmacol. 2007. Vol. 59. P. 795-805. 3. Hofmann M., Stoss O., Shi D., Buttner R., et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study // Histopathology. 2008. Vol. 52(7). P. 797-805.; Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world // J. Clin. Oncol. 2008. Vol. 24. P.2137-2150.; Slamon D.J., Leyland-Jones B., Shak S., Fuchs H. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 // N Engl. J. Med. 2001. Vol. 344(11). P.783-792; Smith I. et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial // Lancet. 2007. Vol. 369. P. 29-36.; Van Cutsem E., Kang Y., Chung H., Shen L., et al. Efficacy results from the ToGA trial: A phase III study of trastruzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC) // JCO. 2009. Abstract 4509.; https://www.surgonco.ru/jour/article/view/185Test
الإتاحة: https://doi.org/10.24060/2076-3093-2013-0-4-16-22Test
https://doi.org/10.24060/2076-3093-2013-0-4Test
https://www.surgonco.ru/jour/article/view/185Test